Header image for  Pareto Securities’ 11th Annual Healthcare Conference
Profile image for Bonesupport

Bonesupport Exhibitor

Type of industry

Medtech

Presentation
BONESUPPORT™ develops and commercializes innovative injectable bio-ceramic bone graft substitutes that remodel to the patient’s own bone and have the capability of eluting drugs. BONESUPPORT’s bone graft substitutes are based on the patented technology platform CERAMENT®. The company portfolio includes the only CE marked injectable antibiotic eluting bone graft substitutes; CERAMENT® G with gentamicin, and CERAMENT® V with vancomycin. Today more than 50.000 patients have been treated with products from the CERAMENT platform. The company is conducting several clinical studies to further demonstrate the clinical and health economic benefits its products deliver and a Premarket approval filing with the FDA (USA) for its gentamicin eluting product is planned in 2020. The company is based in Lund, Sweden. Please visit www.bonesupport.com for more information.

BONESUPPORT and CERAMENT are registered trademarks of BONESUPPORT AB.

Presentations

Bonesupport

Wednesday September 2, 2020 10:00 - 10:30 CEST Room 1

Contact information

Phone

+46 46 286 53 24

Address

Scheelevägen 19

223 70 Lund

Skåne

Sweden

Representatives

Pia Carlsen Exhibitor

Bonesupport

Profile image for Emil Billbäck

Emil Billbäck LecturerExhibitor

CEO
Bonesupport

Exhibitor

Bonesupport

Hakan Johansson Exhibitor

Bonesupport